Risk factors of severe COVID-19: a review of host, viral and environmental factors

L Zsichla, V Müller - Viruses, 2023 - mdpi.com
The clinical course and outcome of COVID-19 are highly variable, ranging from
asymptomatic infections to severe disease and death. Understanding the risk factors of …

Chronic obstructive pulmonary disease and COVID-19: interrelationships

D Singh, AG Mathioudakis… - Current opinion in …, 2022 - journals.lww.com
Chronic obstructive pulmonary disease and COVID-19: interrel... : Current Opinion in
Pulmonary Medicine Chronic obstructive pulmonary disease and COVID-19 …

Impact of COPD on COVID-19 prognosis: A nationwide population-based study in South Korea

SC Lee, KJ Son, CH Han, SC Park, JY Jung - Scientific reports, 2021 - nature.com
Underlying chronic respiratory disease may be associated with the severity of coronavirus
disease 2019 (COVID-19). This study investigated the impact of chronic obstructive …

[HTML][HTML] COVID-19: Why does disease severity vary among individuals?

S Samadizadeh, M Masoudi, M Rastegar, V Salimi… - Respiratory …, 2021 - Elsevier
The novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is
responsible for the current pandemic, coronavirus disease 2019 (COVID-19). While all …

Mechanisms, pathophysiology and currently proposed treatments of chronic obstructive pulmonary disease

SO Rodrigues, CMC Cunha, GMV Soares, PL Silva… - Pharmaceuticals, 2021 - mdpi.com
Chronic obstructive pulmonary disease (COPD) is one of the leading global causes of
morbidity and mortality. A hallmark of COPD is progressive airflow obstruction primarily …

Epidemiology, healthcare resource utilization, and mortality of asthma and COPD in COVID-19: a systematic literature review and meta-analyses

DMG Halpin, AP Rabe, WJ Loke, S Grieve… - Journal of asthma …, 2022 - Taylor & Francis
Purpose There has been concern that asthma and chronic obstructive pulmonary disease
[COPD] increase the risk of developing and exacerbating COVID-19. The effect of …

Organokines in COVID-19: a systematic review

SM Barbalho, G Minniti, VFB Miola, JFS Haber… - Cells, 2023 - mdpi.com
Coronavirus disease 2019 (COVID-19) is a viral infection caused by SARS-CoV-2 that
induces a generalized inflammatory state. Organokines (adipokines, osteokines, myokines …

A critical evaluation of risk to reward ratio of quercetin supplementation for COVID‐19 and associated comorbid conditions

A Pawar, M Russo, I Rani, K Goswami… - Phytotherapy …, 2022 - Wiley Online Library
The interim results of the large, multinational trials on coronavirus disease 2019 (COVID‐19)
using a combination of antiviral drugs appear to have little to no effect on the 28‐day …

[HTML][HTML] Attitudes toward using COVID-19 mHealth tools among adults with chronic health conditions: secondary data analysis of the COVID-19 impact survey

M Camacho-Rivera, JY Islam, A Rivera… - JMIR mHealth and …, 2020 - nursing.jmir.org
Background: Adults with chronic conditions are disproportionately burdened by COVID-19
morbidity and mortality. Although COVID-19 mobile health (mHealth) apps have emerged …

The complex association between COPD and COVID-19

NT Awatade, PAB Wark, ASL Chan… - Journal of Clinical …, 2023 - mdpi.com
Chronic obstructive pulmonary disease (COPD) is significant cause of morbidity and
mortality worldwide. There is mounting evidence suggesting that COPD patients are at …